Hyun Kim

Company: AOBiome Therapeutics

Job title: VP Clinical Operations

Seminars:

Efficacy & Safety of B244: A Live Topical Biotherapeutic, in Patients with Mild to Moderate Atopic Dermatitis & Associated Pruritus 9:15 am

Introducing B244, an ammonia oxidizing bacteria, as a topical spray investigational product Efficacy of B244 in itch relief and lesion control from a 547 patient Phase 2b study in mild to moderate atopic dermatitis Safety profile of B244Read more

day: Day One